KRAS G12V Peptide
KRAS G12V Peptide is a specific peptide derived from the Kirsten rat sarcoma virus (KRAS) gene carrying the G12V oncogenic mutation. KRAS G12V Peptide induces responses like IFN-γ secretion and cytotoxicity. KRAS G12V Peptide can be used for the study of immune responses against KRAS G12V-mutant tumors[1].
Product Specifications
CAS Number
[1932689-39-8]
UNSPSC
12352209
Target
IFNAR
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
O=C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C(C)C)N
Molecular Formula
C40H73N11O11
Molecular Weight
884.07
References & Citations
[1]Zheng W, et al. Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development. Oncol Res. 2024 Nov 13;32 (12) :1837-1850.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6490127-01 0.1 mL
NLK, CT (Nemo-like Kinase, DKFZp761G1211, FLJ21033, LAK1, Protein LAK1, Serine/threonine Protein Kinase NLK) (MaxLight 490)
Ask
View Details 
MBS6490127-02 5x 0.1 mL
NLK, CT (Nemo-like Kinase, DKFZp761G1211, FLJ21033, LAK1, Protein LAK1, Serine/threonine Protein Kinase NLK) (MaxLight 490)
Ask
View Details